Retail representatives from States to discuss situation in Mumbai today <\/p>\n
Hyderabad\/Chennai\/Mumbai, Sept. 3: <\/p>\n
Shubas father-in-law had carried only a limited stock of his asthma medicine when he travelled from Payyanur (Kerala) to Mumbai to spend time with his children. After all, the medicine could be bought at pharmacies anywhere in the country. <\/p>\n
But that was not to be, as the family found out when he exhausted his stock. The medicine was not available with chemists in Mumbai, Payyanur or Chennai and Shuba had to call the doctor in Kerala to get an alternative to this asthma medicine. <\/p>\n
Supplies of some medicines are falling short across the country, as companies are in the process of withdrawing stocks with the old prices and replacing them with new batches bearing the revised price. This exercise follows the Governments new drug pricing policy that aims to make medicines more affordable. <\/p>\n
But Sanjay, a Hyderabad-based chemist, anticipates medicine shortages. The (Government) order mandates us to sell the drugs at a reduced price. The new packs with changed MRPs are yet to come, while the distributors may not be willing to push the stock (with old rates) on hand,\" he points out. <\/p>\n
P. Elango, General-Secretary of Tamil Nadu Pharmaceutical Distributors Association (TNPDA), says the shortfall in the State pertains only to a few premium brands. <\/p>\n
Some companies had gone to Court on the issue and were given some interim relief, provided they gave their list of revised medicine prices to the chemists. But G. Somaskandan, TNPDA General-Secretary (Chennai), says many manufacturers have failed to send the price lists along with the repackaged stocks. <\/p>\n
NPPA chief C.P. Singh, however, said there were no reports of shortages from across the country. Officials with the Food and Drug Administration in Maharashtra and Gujarat point out that low-priced alternatives are available in the market, as only high-priced drugs listed as essential needed a revision. <\/p>\n
Trade margins are a concern, as the DPCO (Drug Price Control Order) 2013 reduces the margins for retailers and wholesalers, said J.S. Shinde, who heads the All India Chemists and Druggist Association. The earlier margins were 20 per cent to the retailer and 10 per cent to the wholesaler, which comes down to 16 per cent and eight per cent, respectively. <\/p>\n
<\/p>\n
Go here to see the original: <\/p>\n
Medicine shortage being felt across the country<\/a><\/p>\n","protected":false},"excerpt":{"rendered":" Retail representatives from States to discuss situation in Mumbai today Hyderabad\/Chennai\/Mumbai, Sept. 3: Shubas father-in-law had carried only a limited stock of his asthma medicine when he travelled from Payyanur (Kerala) to Mumbai to spend time with his children. After all, the medicine could be bought at pharmacies anywhere in the country. Continue reading